MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This Phase III clinical trial will examine the safety, tolerability, and efficacy of the
addition of MK-0431/ONO-5435 to Japanese patients with Type 2 Diabetes mellitus who have
inadequate glycemic control on diet/exercise therapy and rapid-acting insulin secretagogue
monotherapy.